Modis Therapeutics
About:
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Website: https://www.modistx.com/
Top Investors: OrbiMed, F-Prime Capital, OUP (Osage University Partners), Aceras Life Sciences
Description:
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Total Funding Amount:
$30M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Oakland, California, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)modistx.com
Founders:
Daniel DiPietro, Peter Barber
Number of Employees:
1-10
Last Funding Date:
2018-10-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai